Approved Documents
DTC Supplements
2009 / 2010 / 2011
| 2011 | ||
| Nov 2011 |
|
Specialist list - Stroke. Specialist lists - Progress Drug Safety Updates - November Systemic fusidic acid - interaction with statins Antipsychotics during third trimester of pregnancy - newborn effects Adrenaline tartrate Citalopram - QT interval prolongation SMC Advice issued in October 2011: - Adrenaline tartrate - Boceprevir - Botulinim toxis type A - Bromfenac - Conestat alfa - Eribulin - Fluorouracil - Infliximab - Olmesartan medoxomil/amlodipine/besitate/hydrochlorothiazide - Quetiapine - Rosuvastatin - Vardenafil Updates from previous SMC Advice: - Retigabine -TAF Updates - November 2011 SMC Briefing Note - October 2011 Forthcoming SMC Advice |
| Oct 2011 | Issue 110 |
Specialist lists - Chronic
Pain Ketamine Oral Solution Drug Safety Updates - October Dronedarone - safety review Individual Patient Treatment Requests (IPTRs) approved in secondary care Tapentadol prolonged-release tablets SMC Advice issued in September 2011: - Abatacept - Azacitidine - Dabigatran etexilate - Golimumab - Tenofovir Updates from previous SMC Advice: - Memantine - Methotrexate - Mifamurtide - Tapentadol TAF Updates - October 2011 SMC Briefing Note - September 2011 Forthcoming SMC Advice |
| Sept 2011 | Issue 109 |
Specialist
lists - update Specialist lists - Stroke Ezetimibe - algorithms for review of prescribing Lidocaine 5% medicated plaster Drug Safety Updates - August and September 2011 High dose antioxidants & zinc in AMD Dabigatran - prevention of stroke Non-calcium based phosphate binders SMC Advice issued in July 2011: - Paliperidone palmitate - Prucalopride - Ranibizumab - Retigabine - Trabectedin SMC Advice issued in August 2011: - Alteplase - Bilastine - Calcium carbonate - Capecitabine - Collagenase clostridium histolyticum - Darunavir - Glucosamine suophate - Methotrexate - Mifamurtide - Nilotinib Updates from previous SMC Advice: - Ferric carboxymaltose - Iron isomaltoside TAF Updates - Sept 2011 SMC Briefing Notes - July and August 2011 Forthcoming SMC Advice |
| August 2011 |
|
Special
Focus on Oncology & haematology SMC Advice: Introduction Oncology & Haematology Protocols Updates from previous SMC Advice (Oncology/Haematology 2004-2011): - Bortezomib - Carmustine - Degarelix - Docetaxel - Erlotinib - Exemestane - Imatinib - Letrozole - Nilotinib - Pemetrexed - Rituximab - Sunitinim - Thalidomide - Topotecan |
| July 2011 | Issue 107 |
Specialist
lists - Palliative Care Specialist lists - Rheumatology Thalidomide and thromboembolism Drug Safety Update - June 2011 SMC Advice issued in June 2011: - Ferric carboxymaltose - Filgrastim - Omalizumab - Tapentadol - Triptorelin Updates from previous SMC Advice (2007-2011): - Buprenorphine/naloxone TAF Updates - July 2011 SMC Briefing Note - June Forthcoming SMC Advice |
| May/June 2011 | Issue 106 |
Specialist
lists - Renal Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer's Disease SMC Advice issued in May 2011: - Iron isomaltoside - Quetiapine - Sunitinib - Tadalafil - Ticagrelor - Tocofersolan Updates from previous SMC Advice: - Calcium acetate Drug Safety Update - May 2011 TAF Updates - May 2011 SMC Briefing Note - May Forthcoming SMC Advice |
| Apr/May 2011 | Issue 105 |
Specialist
lists - Update Drug Safety Updates: - Tigecycline - Atypical (second generation) antipsychotics SMC Advice issued in April 2011: - Bendamustine hydrochloride - Bendamustine powder (multiple myeloma) - Bendamustine powder (non-hodgkin's lymphomas) - Botulinum toxin type A - Calcium acetate/magnesium carbonate - Cannabinoid oromucosal spray - Drospirenone/Ethinylestradiol - Paliperidone - Sevelamer carbonate SMC Briefing Note - April Forthcoming SMC Advice |
| Mar/Apr 2011 | Issue 104 |
Specialist
lists - Update Denosumab protocol Parathyroid hormone protocol - update Drug Safety Update - February 2011 Drug Safety Update - March 2011 Pioglitazone and insulin - risk of cardiac failure Sugammadex Treatment of erectile dysfunction in patients with severe distress Electronic access to Martindale, Stockley and DTB SMC Advice issued in March 2011: - Adapalene - Botulinum toxin type A solution for injection - Botulinum toxin type A - Dalteparin sodium - Exenatide - Fosaprepitant dimeglumine - Pazopanib - Sildenafil cigtratre - Vinflunine ditartrate Updates from previous SMC Advice: - Denosumab TAF Updates - March/April 2011 SMC Briefing Note - March Forthcoming SMC Advice |
| Feb/Mar 2011 |
|
Specialist
lists - Respiratory NHS Scotland Palliative Care Guidelines Dronedarone protocol - update & amended advice Topiramate protocol - update Review of local processing of SMC accepted advice Drug Safety Update - January 2011 SMC Advice issued in February 2011: - Capsaicin - Colesevelam - Fenticonazole - Filgrastim - Golimumab - Ivabradine - Miconazole - Rituximab - Trastuzumab Updates from previous SMC Advice: - Eslicarbazepine acetate - Degarelix - Prilocaine hydrochloride TAF Updates - Feb/Mar SMC Briefing Note - February Forthcoming SMC Advice |
| Jan/Feb 2011 |
Specialist
lists - progress Omalizumab - treatment protocol Drug Safety Update SMC Advice Issued in January 2011: - Botulinum toxin type A (Azzalure®) - Botulinum toxin type A (Vistabel®) - Degarelix - Erlotinib - Fentanyl nasal spray - Ferric carboxymaltose - Histamine dihydrochloride - Levetiracetam - Prilocaine hydrochloride - Sorafenib - Valganciclovir - Valsartan - Velaglucerase Updates from previous SMC Advice: - Fentanyul sublingual tablets - Fentanyl buccal tablets - Fentanyl nasal spray - Oxycodone - Moxifloxacin TAF Updates - January/February SMC Briefing Note - January Forthcoming SMC Advice |
|
| 2010 | ||
| Dec 10/Jan 2011 | Issue 101 |
Melatonin
shared care agreement Parenteral methotrexate policy Topical tacrolimus protocol Prescribing of liraglutide or exenatide with insulin Codeine containing liquids - OTC medicines should not be used for cough in the under 18's Safety of inhaled tiotropium Tamoxifen and drug interactions with CYP2D6 inhibitors Withdrawal of Mixtard 30 insulin Change in formulation of etonogestrel implant SMC Advice Issued in December 2010/January 2011: - Atazanavir - Denosumab (osteoporosis) - Denosumab (bone loss) - Dexamethasone - Diclofenac - Etonogestrel implant - Fondaparinux sodium - Gefitinib - Moxifloxacin - Prucalopride - Ranolazine - Tacrolimus granules Updates from previous SMC Advice: - Dutasteride - Febuxostat - Lacosamide - Methotrexate injection - O)xycodone - Tacrolimus 0.03% ointment - Tacrolimus 0.1% ointment TAF Updates - December SMC Briefing Note - December Forthcoming SMC Advice |
| Oct/Nov 2010 |
Dermatology Biologics Guidelines Dronedarone - changes to the local protocol Oral bisphosphonates and oesophageal cancer Levothyroxine oral solution - change in formulation Choice of Combined Oral Contraceptives SMC Advice Issued in October/November 2010: - Amifampridine - Canakinumab - Certolizumab pegol - Docetaxel - Eculizumab - Eslicarbazepine acetate - Ethinylestradiol (Geradel®) - Ethinylestradiol (Millinette®) - Ethinylestradiol (Rigevidon®) - Ethinylestradiol (TriRegol®) - Glucosamine sulphate - Lanthanum carbonate - Oxycodone hydrochloride - Pemetrexed - Roflumilast - Sevelamer - Trabectedin Updates from previous SMC Advice: - Bivalirudin - Esomeprazole - Infliximab - Ivabradine - Pregabalin - Tadalafil - Tocilizumab - Ustekinumab TAF Updates MAG meetings SMC Briefing Notes Forthcoming SMC Advice |
|
|
Guidelines
on Biological Treatment of Severe Psoriasis |
||
| Aug/Sept 2010 | Issue 98 |
Special focus on drugs in
Diabetes: Introduction Rosiglitazone and Cardiovascular Risk Updates to Section 6.1 of the Formulary Summary of changes to local recommendations |
| June/July 2010 | Issue 97 |
Minor changes in formulary
categories of SMC Advice NICE (Multiple) Technology Appraisal Guidance No 88 - Somatropin for the treatment of growth failure in children Drug Safety Updates: - Carbapenems: concomitant use with valproic acid not recommended - Quinine: not to be used routinely for nocturnal leg cramps - Risk of medication errors with rivastigmine transdermal patches SMC Advice Issued in June/July 2010: - Certolizumab pegol - Corifolitropin alfa - Epoetin theta - Ketoprofen/omeprazole - Lapatinib - Mifamurtide - Miglustat - Sitagliptin Updates from previous SMC advice: - Fluticasone furoate - Beclometasone - Omalizumab SMC briefing notes TAPG Updates Forthcoming SMC Advice |
| Apr/May 2010 | Issue 96 |
Generic clopidogrel
prescribing and licensed indications Simvastatin increased risk of myopathy at high dose (80mg) Clopidogrel and Proton Pump Inhibitors (PPIs) - An Update New edition of the TAPG Pocket Guide Delayed antibiotic prescriptions in Primary Care SMC Advice Issued in April/May 2010: - Abatacept - Azacitidine - Everolimus - Extended release nicotinic acid/laropiprant - Gefitinib - Lenalidomide - Metformin - Omalizumab - Paclitaxel albumin - Raltegravir - Sitagliptin - Tacrolimus 0.03% ointment - Tacrolimus 0.1% ointment - Telmisartan - Temsirolimus Updates from previous SMC advice: - Esomeprazole - Saxagliptin - Ulipristal acetate - Valganciclovir SMC briefing note TAPG Updates Forthcoming SMC Advice |
|
Feb/Mar 2010
|
Issue 95
|
Tayside switch to ferrous
fumarate Creon patient information leaflet SMC Advice Issued in February/March 2010: - Aliskiren - Calcium acetate - Cetuximab - Darunavir - Epoetin alfa - Extended release epidural morphine - Ketoprofen/omeprazole - Pemetrexed - Rupatadine - Saxagliptin - Sildenafil - Somatropin for injection - Tipranavir oral solution - Tipranavir soft capsule - Trospium chloride - Ulipristal acetate - Ustekinumab Updates from previous SMC advice: - Darunavir - Etravirine - Prasugrel SMC briefing note TAPG Updates Forthcoming SMC Advice |
| 2009 | ||
|
Bisphosphonates - change in
local prescribing advice Recommendation for suspension of sibutramine (Reductil) Exenatide - Revision of the new medicine treatment protocol and local recommendation Pega-tanib - Update SMC Advice Issued in December 2009 and January 2010: - Bemiparin - Eslicarbazepine - Imatinib - Liraglutide - Plerixafor - Pramipexole dihydrochloride monohydrate - Rituximab - Tafluprost - Tocilizumab - Tolvaptan - Valganciclovir (CMS) - Valganciclovir (CMV) Updates from previous SMC advice: - Etonogestrel - Fentanyl - Rotigotine TAPG Update Forthcoming SMC Advice |
||
| Oct/Nov | Issue 93 |
SMC Advice Issued in October
and November 2009 Agomelatine Bortezomib Esomeprazole Estradiol/dienogest Etonogestrel/ethinylestradiol vaginal ring Fentanyl nasal spray Filgrastim Hydroxycarbamide Metformin hydrochloride prolonged release Methotrexate injection Nepafenac Olmesartan medoxomil/amlodipine as besilate Quetiapine Romiplostim Sunitinib Vildaglliptin Etanercept - Update Clopidogrel and PPIs - Update Clopidogrel and Other Medicines that inhibit CYP2C19 Droperidol injection Levomepromazine use in palliative care TAPG documentation update TAPG Update Forthcoming SMC Advice |
| Aug/Sept | Issue 92 |
SMC Advice Issued in August
and September 2009 Brinzolamide/timolol eye drops Calcipotriol and betamethasone dipropionate Darunavir Degarelix Etanercept Etoricoxib Etravirine Fosamprenavir Histrelin Lamivudine/zodovudine Mecasermin Peginterferon alfa-2a Prasugrel Ranolazine Rotigotine Calcipotriol and betamethasone dipropionate gel - Prescribing notes Glyceryl Trinitrate Buccal tablets Pregabalin Update Priadel Liquid Rotigotine transdermal patches - lifting of prescribing restrictions Rivaroxaban local treatment protocol - minor change TAPG Update Forthcoming SMC Advice |
| July | Issue 91 |
SMC Advice Issued in July 2009 Enoxaparin Infliximab Pegylated liposomal doxorubicin Terlipressin acetate Tadalafil Update TAPG Update Forthcoming SMC Advice |
| June | Issue 90 |
SMC Advice Issued in June 2009 Aripiprazole tablets Pemetrexed Rituximab Sapropterin Tadalafil Use of PPIs with clopidogrel New advice on oral salicylate gel for those younger than 16 years MAG meetings Forthcoming SMC Advice |
| May | Issue 89 |
SMC Advice Issued in May 2009 Caffeine base solution for injection Caspofungin powder Paclitaxel Pregabalin Caffeine base solution for injection - prescribing note Updates from previous SMC Advice TAPG Update Drug Interactions with Statins Use of PPIs with clopidogrel Forthcoming SMC Advice |
| April | Issue 88 |
SMC Advice Issued in April
2009 Brinzolamide 10mg/ml eye drop Budesonide CFC-free inhaler Cetuximab Micronised progesterone Topotecan Sunitinib - NICE Guidance No 169 TAPG Update Note advising access to TAPG on home page of Staffnet Forthcoming SMC Advice |
| March | Issue 87 |
SMC Advice Issued in March
2009 Alitretinoin 10mg/30mg capsules Betaine anhydrous oral powder Cetuximab 5mg/ml solution for infusion Cladribine 2mg.ml solution for injection Doripenem 500mg powder for infusion Oxycodone/naloxone prolonged release tablets Testosterone undecanoate oily solution for injection Tobramycin 300mg/4ml nebuliser solution Suggested monitoring requirements for alitretinoin TAPG Update Forthcoming SMC Advice |
| January/February | Issue 86 |
SMC Advice Issued in January
and February
2009 Adalimumab Aliskirin Buprenorphine transderemal patches Doripenem Etonogestrel/ethinylestradiol Etravirine Extended release epidural morphine Fentanyl buccal tablets Fentanyl sublingual tablets Lacosamide Lapatinib Pemetrexed Salmeterol/fluticasone inhaler Stiripentol Sugammadex Thalidomide Zoledronic acid Updates from previous SMC advice Melatonin use in sleep disorders in children TAPG Update Forthcoming SMC Advice |
Home | TAPG | New Medicines | Policies | Links